Introduction {#Sec1}
============

Adrenalectomies are becoming more frequent worldwide. Contemporary imaging techniques with an increased detection of adrenal incidentalomas and new surgical techniques with reduction of morbidity and mortality with endoscopic methods \[[@CR1], [@CR2]\] have contributed to the increase in operations. In 1992, Gagner et al. were among the first to describe laparoscopic adrenalectomy \[[@CR3]\]. Since then, several studies have evaluated minimally invasive surgery for adrenal lesions, which has become the standard technique for surgical treatment of adrenal tumours \[[@CR4], [@CR5]\]. Previous studies have compared laparoscopic with open adrenalectomy for complications, hospital stay, morbidity and mortality \[[@CR2], [@CR6], [@CR7]\]. Laparoscopic adrenalectomy is widely used in both university hospitals and smaller units. Studies have evaluated risk factors for complications associated with surgical technique, surgeon volume and patient-related risk factors. Most of the studies are single-centre studies \[[@CR8]--[@CR10]\], although a few national studies that included specific hospitals or patient groups are available \[[@CR11]--[@CR13]\].

Adrenalectomies in Sweden have been registered in the Scandinavian Quality Register for Thyroid, Parathyroid and Adrenal Surgery (SQRTPA) as of 2009. All hospitals that perform adrenal surgery are participating in the registry. The aim of the present study was to evaluate a national experience of adrenal surgery over 6 years and to determine risk factors for complications, conversion from endoscopic to open surgery and prolonged hospital stay.

Material and methods {#Sec2}
====================

Register background {#Sec3}
-------------------

The SQRTPA was established 2004. In 2009, a module for adrenal surgery was added. The register is an online database and is recognized by the Swedish National Board of Health and Welfare as the national registry within the field.

Patients who underwent adrenal surgery and were reported in the registry 2009--2014 were included in the study. All procedures were performed by endocrine surgeons. Follow-up was performed at 4--6 weeks postoperatively.

Data variables {#Sec4}
--------------

Data were collected for age, gender, body mass index (BMI), hypertension, radiographic tumour size (largest diameter measured on adrenal-CT or MRI), side for adrenal tumour, indication for surgery, surgical technique, histopathology, conversion rate from endoscopic to open surgery, complications (bleeding with transfusion, laceration of viscus, pneumothorax, local infection/abscess and re-operation), postoperative length of stay and 30-day mortality.

Surgical techniques were grouped for the analysis. Endoscopic adrenalectomy included laparoscopic adrenalectomy (posterior and transabdominal) and robotic-assisted laparoscopic adrenalectomy (posterior and transabdominal). Open adrenalectomy included laparotomy, thoracoabdominal approach and open retroperitoneal operations. The technique used was determined by the surgeon on the basis of preoperative findings, availability of equipment and surgical experience.

The primary outcomes were risk factors affecting conversion rate, complication rate and postoperative length of stay (LOS).

The secondary outcomes were variables associated with a surgical technique, laparoscopic, versus robot-assisted adrenalectomy and endoscopic versus open adrenalectomy.

Statistical analysis {#Sec5}
--------------------

Descriptive statistics are presented as number with valid per cent or median with minimum and maximum values. Binary logistic regression was used to analyse the association between outcome variables and predictors. Analysed outcome variables were complication (defined as bleeding with transfusion, laceration of viscus, pneumothorax, local infection or abscess and re-operation (no or yes)), re-operation (no or yes), conversion (no or yes), postoperative days before discharge (1--3 and 4--30), technique (endoscopic, open) and technique (laparoscopic, robotic). The predictors that were assessed were age, sex, BMI (less than 25 or 25 and higher), adrenal tumour side (right or left or bilateral), largest tumour size, surgical technique (laparoscopic, robotic, open), clinical syndrome of hormonal excess (none, cathecholamines, cortisol and subclinical Cushing syndrome, aldosterone), histopathology (malignant, phaeochromocytoma, other benign lesions) and conversion from endoscopic to open surgery (no or yes). Univariable analyses were conducted, and each outcome variable was assessed with each predictor. Forward multiple linear regression analyses were performed to identify models with significant predictors for each outcome variable, except for re-operation due to small numbers of events. The results from the binary logistic regressions are shown as numbers, odds ratios with 95% confidence intervals (CI) and *p* values.

All analyses were conducted using IBM SPSS Statistics 22 for Windows (IBM Corporation, Armonk, NY, USA). We considered *p* values below 0.05 as statistically significant.

Results {#Sec6}
=======

Some 659 patients underwent adrenalectomy under the 6-year period in ten surgical departments. The distribution between centres is shown in Table [1](#Tab1){ref-type="table"}. Preoperative characteristics of the cohort are summarized in Table [2](#Tab2){ref-type="table"}.Table 1Distribution of patients between medical centres*n* = 659 (%)OpenLaparoscopicRobotUniversity hospital 1235 (35.7)855172 2179 (27.2)307277 3143 (21.7)331091 462 (9.4)16460 520 (3.0)4160County hospital 612 (1.8)1110 74 (0.6)310 82 (0.3)020 91 (0.15)010 101 (0.15)100Valid percent*n* number Table 2Results of preoperative clinical variables for the patients included in the study*n* = 659PercentAge (median, year)59 (8--89)Female372(56.4)BMI ≥ 25373(64.1)Hypertension215(32.6)Tumour side Left375(56.9) Right254(38.5) Bilateral30(4.6)Tumour size (median, mm)35 (1--200)Operation indication Clinical syndrome of hormonal excess399(60.5) Suspected malignancy on radiology215(32.6) Suspected malignancy on cytology27(4.1) Metastasis32(4.9) Size only (≥40 mm)75(11.4)Valid percent. Median (min-max)*BMI* body mass index, *n* number

The median age was 59 (range 8--89) years, and 372 (56.4%) patients were women. Some 215 (32.6%) patients had hypertension defined as blood pressure \>140/90 mmHg. On radiological examination, the median size of the tumour was 35 mm (range 1--200).

Indication for operation could be one or several. The most common indication was a clinical syndrome of hormonal excess; 161 (24.4%) patients had hormonal excess of aldosterone, 113 (17.1%) patients had hypersecretion of cathecholamines, and 118 (17.9%) patients had hypercortisolism. In 215 (32.6%) patients, malignancy was suspected on the basis of radiological examination (CT or MRI). Some 32 (4.9%) patients had preoperatively diagnosed metastases and 75 (11.4%) patients underwent surgery because of a tumour size larger than 40 mm.

Perioperative characteristics are shown in Table [3](#Tab3){ref-type="table"}. Final pathologic diagnosis was, among others, adrenal cortical adenoma in 262 (49.6%) patients and phaeochromocytoma in 100 (18.9%) patients. In total, 71 (13.3%) patients had a diagnosis of malignancy.Table 3Results of intra- and postoperative variables for the patients included in the study*n* = 659PercentSurgical technique Laparoscopic263(39.9) Robotic250(37.9) Open146(22.2)Histopathology (*n* = 528) Malignant71(13.4) Phaeochromocytoma100(18.9) Other benign357(67.6)Conversion37(5.6)Complication Bleeding with transfusion17(2.6) Local infection/abscess8(1.2) Pneumothorax3(0.5) Laceration of viscus5(0.8) Re-operation10(1.5)30-day mortality0(0)Length of hospital stay (median, days)3 (1--30)Valid percent. Median (min-max)*n* number

Endoscopic adrenalectomy was performed in 513 (77.8%) patients and almost half of these operations were robotically assisted. In total, 146 (22.2%) patients were operated with open procedures and in 37 (5.6%) patients, conversion was performed from endoscopic to open surgery.

Some 43 (6.5%) patients had a complication and the most common was bleeding with transfusion. The 30-day mortality rate was nil. Median LOS was 3 (range 1--30) days.

Analysis of primary outcomes {#Sec7}
----------------------------

Univariable and multivariable logistic regression analysis was performed for the primary outcomes. Predictive factors for complications, conversion and LOS are presented in Tables [4](#Tab4){ref-type="table"}, [5](#Tab5){ref-type="table"} and [6](#Tab6){ref-type="table"}, respectively.Table 4Uni- and multivariable regression analysis of risk factors for complication after adrenalectomyUnivariable logistic regressionMultivariable logistic regression*n*OR (95% CI)*pn*OR (95% CI)*p*Age6581.02 (1.00--1.04)0.109Sex Female371Ref Male2871.38 (0.75--2.53)0.295BMI \<25209Ref. ≥253720.73 (0.39--138)0.336Tumour side0.603 Right254Ref. Left3741.39 (0.73--2.64)0.315 Bilateral300.00 (0.00-.)0.998Largest tumour size6571.01 (1.01--1.02)\<0.001Surgical technique0.0010.112 Laparoscopic262Ref.212Ref. Robotic2500.69 (0.30--1.56)0.3681710.79 (0.33--1.92)0.604 Open1462.61 (1.29--5.28)0.007842.03 (0.85--4.84)0.109Clinical syndrome of hormonal excess0.157 None260Ref. Cathecholamines1130.44 (0.16--1.17)0.098 Cortisol1170.42 (0.16--1.13)0.084 Aldosterone1610.62 (0.29--1.33)0.222Histopathology0.178 Other benign357Ref. Malignant711.84 (0.79--4.31)0.157 Phaeochromocytoma1000.61 (0.2--1.79)0.364Conversion No621Ref.449Ref. Yes372.89 (1.14--7.34)0.026183.61 (1.07--12.12)0.038Complications that were analysed were bleeding with transfusion, laceration of viscus, pneumothorax, local infection or abscess and re-operation analysed together*BMI* body mass index, *OR* odds ratio, *CI* confidence interval, *Ref.* referent Table 5Uni- and multivariable logistic regression analysis of risk factors for conversion from endoscopic to open surgeryUnivariable logistic regressionMultivariable logistic regression*n*OR (95% CI)*p* value*n*OR (95% CI)*p* valueAge6591.01 (0.99--1.04)0.274Sex Female372Ref. Male2871.11 (0.57--2.16)0.762BMI \<25209Ref. ≥253731.07 (0.49--2.34)0.869Tumour side0.387 Right254Ref. Left3750.62 (0.31--1.23)0.174 Bilateral300.94 (0.21--4.25)0.932Largest tumour size6581.00 (0.99--1.01)0.4823831.03 (1.00--1.06)0.026Surgical technique Laparoscopic263Ref. Robotic2505.14 (1.46--18.11)0.011Clinical syndrome of hormonal excess0.030 None260Ref. Cathecholamines1130.38 (0.13--1.12)0.079 Cortisol1180.65 (0.27--1.56)0.335 Aldosterone1610.20 (0.06--0.66)0.009Histopathology0.2080.005 Other benign357Ref.291Ref. Malignant712.44 (0.9--6.66)0.081248.33 (2.12--32.07)0.002 Phaeochromocytoma1001.10 (0.35--3.46)0.87680.67 (0.08--5.73)0.718*BMI* body mass index, *OR* odds ratio, *CI* confidence interval, *Ref.* referent Table 6Uni- and multivariable logistic regression analysis of variables associated with postoperative length of stayUnivariable logistic regressionMultivariable logistic regression*n*OR (95% CI)*pn*OR (95% CI)*p*Age6521.02 (1.01--1.03)0.003Sex Female368Ref Male2841.13 (0.82--1.55)0.461BMI \<25208Ref. ≥253670.96 (0.68--1.35)0.799Tumour side0.2990.021 Right253Ref.177Ref. Left3701.06 (00.76--1.47)0.7332641.98 (1.14--3.43)0.016 Bilateral291.84 (0.85--3.99)0.120233.13 (1.08--9.06)0.035Largest tumour size6511.03 (1.03--1.04)\<0.001Surgical technique\<0.001\<0.001 Laparoscopic261Ref.211Ref. Robotic2501.72 (1.13--2.60)0.0111711.56 (0.95--2.56)0.081 Open14146.51 (23.84--90.72)\<0.00182115.18(32.94--402.67)\<0.001Clinical syndrome of hormonal excess\<0.0010.012 None255Ref.162Ref. Cathecholamines1131.03 (0.66--1.61)0.884842.32 (1.18--4.59)0.015 Cortisol1161.06 (0.68--1.64)0.805861.56 (0.77--3.18)0.219 Aldosterone1610.25 (0.16--0.41)\<0.0011320.78 (0.40--1.51)0.458Histopathology\<0.001 Other benign356Ref.\<0.001 Malignant705.09 (2.94--8.81)0.006 Phaeochromocytoma991.91 (1.21--3.03)Conversion No617Ref.447Ref. Yes3514.18 (4.94--40.71)\<0.0011742.05 (5.02--352.40)0.001Postoperative days before discharge, 1--3 (ref.) versus 4--30*BMI* body mass index, *OR* odds ratio, *CI* confidence interval, *Ref.* referent

Univariable analysis showed that open surgery, large tumour size and conversion to open surgery were associated with an increased risk of complications. However, in the multivariable analysis, conversion from endoscopic to open surgery was the only independent predictive factor for postoperative complications, OR 3.61 (CI 1.07--12.12). Open surgery was also a risk factor when the surgical techniques were grouped as endoscopic versus open technique, OR 2.26 (CI 1.03--4.93), but when the operations were divided into laparoscopic, robotic and open surgery, the significance was lost (Table [4](#Tab4){ref-type="table"}).

The risk for conversion was increased in robotic-assisted surgery, OR 5.14 (CI 1.46--18.11), in the univariable analysis. However, in the multivariable analysis, only tumour size, OR 1.03 (CI 1.00--1.06), and malignant histopathology, OR 8.33 (CI 2.12--32.07), remained predictive (Table [5](#Tab5){ref-type="table"}).

In the multivariable analysis of LOS, tumour on the left side, OR 1.98 (CI 1.14--3.43), bilateral tumours, OR 3.13 (CI 1.08--9.06), open surgery, OR 115.18 (CI 32.94--402.67), excess of cathecholamines, OR 2.32 (CI 1.18--4.59), and conversion to open surgery, OR 42.05 (5.02--352.40), were independent predictive factors for longer hospital stay (Table [6](#Tab6){ref-type="table"}).

Secondary outcomes {#Sec8}
------------------

In the univariable analysis of patient characteristics and variables depending on the technique used, older age, large tumour size, malignant histopathology and phaeochromocytoma were positively associated with open surgery when compared with endoscopic surgery. A body mass index of 25 or higher, left-sided tumours, and hypercortisolism or aldosteronism were negatively associated with open surgery.

In multivariable logistic regression analysis, larger tumour size OR 1.06 (CI 1.04--1.07) and malignant histopathology OR 11.13 (CI 4.82--25.70) were positive predictive factors for open surgery. ([Suppl](#MOESM1){ref-type="media"}. Table [1](#Tab1){ref-type="table"} for the web).

When comparing robotic-assisted and laparoscopic adrenalectomy, older age and larger tumour size were associated with robotic-assisted adrenalectomy in the univariable analysis. In the multivariable logistic regression analysis, older age, OR 1.02 (CI 1.00--1.03), was borderline significant and larger tumour size, OR 1.02 (CI 1.01--1.03), remained the predictive factor for robotic-assisted surgery. ([Suppl](#MOESM1){ref-type="media"}. Table [2](#Tab2){ref-type="table"} for the web).

Discussion {#Sec9}
==========

In this national cohort of 659 patients undergoing adrenalectomy, some 5.1% patients had at least one complication and 1.5% required re-operation. The only predictive factor associated with complications was conversion from endoscopic to open surgery. In total, 5.6% of the procedures were converted from endoscopic to open surgery and the risk for conversion was related to larger tumour size and malignant tumours. There were no in-hospital deaths and the 30-day mortality was nil. Factors affecting LOS were left-sided tumour, bilateral tumours, open surgery, excess of cathecholamines and conversion to open surgery.

Laparoscopic adrenalectomy is the standard treatment for adrenal tumours \[[@CR4]\]. The technique has a low rate of complications, less postoperative pain, shorter LOS and lower morbidity compared with open surgery \[[@CR7], [@CR14]--[@CR16]\]. Laparoscopic adrenalectomy is therefore cost-effective. There has been an increase in adrenalectomy due to routine imaging and surgical techniques. Benign disease or tumours of unclear significance account for most of the increase \[[@CR17]\]. The laparoscopic technique has evolved from transabdominal to posterior endoscopic and robotic-assisted surgery. Current studies recommend open surgery in malignant or large tumours (\>100 mm) but some recent studies show equivalent results for laparoscopic surgery regarding morbidity and mortality, providing oncological principles are adhered to \[[@CR18]--[@CR21]\]. In very large or locally invasive tumours, an open surgical approach is recommended to facilitate en bloc excision of the tumour \[[@CR22]\]. It has therefore been recommended that these patients should be treated in specialized centres in order to improve outcomes \[[@CR23], [@CR24]\].

There are earlier reports concerning complications in adrenalectomy. Most of them compare outcomes following laparoscopic versus open procedures and most of them are single institution studies from tertiary centres. A lack of standardized definition of complications influences the ability to compare results. Eichhorn-Warry et al. used the Clavien-Dindo classification \[[@CR25]\] and found that laparoscopic adrenalectomy decreased the use of intensive care for complications when compared with open procedures \[[@CR7]\]. There are only few retrospective, national investigations and none of them included all hospitals that perform adrenalectomies \[[@CR6], [@CR11]--[@CR13]\]. It is therefore interesting that the incidence of reported complications in the literature in general is similar to what was shown in the present study \[[@CR1], [@CR10], [@CR11], [@CR13], [@CR26], [@CR27]\]. In the present investigation, conversion to open surgery was the only independent risk factor for complication. Although this could partly be due to bias with larger tumours being at higher risk for conversion, it could be of importance to consider when choosing surgical technique for the individual patient. For some patients, an open approach may be preferred to endoscopic adrenalectomy. The proportion of open procedures in the present report, 22.2%, is comparable with earlier studies \[[@CR6], [@CR7]\].

Bergamini et al., showed that age, BMI, tumour size and phaeochromocytoma are risk factors for complications but these in general were lower in referral than in non-referral centres \[[@CR11]\]. Surgeon volume influences outcome as well and has been shown by Park et al. \[[@CR28]\]. Furthermore, comorbidity has been associated with a risk for complications \[[@CR1], [@CR13]\]. These variables were not registered in the database used for the present investigation, and therefore, the possible influence of these potential risk factors could not be evaluated.

Considering the well-known effects of hypercortisolism, Cushing's syndrome was expected as a risk factor for impaired wound healing, bleeding and postoperative infection after adrenalectomy. However, this was not shown in the present study. In contrast, Sommerey et al. found that bilateral adrenalectomy for Cushing's disease had more severe complications \[[@CR29]\].

The conversion rate in the present study, 5.6%, was consistent with previous reports \[[@CR8], [@CR10]\]. Bittner et al. collected data retrospectively from 402 patients and found that tumour size \>80 mm was a predictive factor for conversion from endoscopic to open surgery \[[@CR8]\]. This is comparable to the present results and indicates that laparoscopic adrenalectomy is used for increasingly larger lesions.

Length of hospital stay is similar in many reports and is shorter after laparoscopic than open procedures \[[@CR6], [@CR8], [@CR9], [@CR13]\]. Independent predictive factors for risk for longer hospital stay are not well explored. Of interest is that low surgeon volume and some comorbidities are associated with higher LOS \[[@CR1], [@CR28]\]. However, these factors were not evaluated in the present study.

Almost half of the endoscopic operations in this cohort, 37.9% in total, were robotic assisted. Robotic-assisted surgery was used in older patients and more importantly in patients with larger tumours. In the univariable analysis, there was a tendency towards a higher conversion rate compared with the standard laparoscopic technique. However, this association was lost in the multivariable analysis. Several retrospective studies on the use of robotic-assisted adrenalectomy have been published during recent years and all reported on small patient groups \[[@CR30], [@CR31]\]. In a meta-analysis, some advantages for robotic surgery compared with conventional laparoscopic surgery were shown such as shorter hospital stay, less intraoperative blood loss and lower risk for postoperative complications \[[@CR32]\]. However, given the scarce data, these results should be interpreted with caution. The benefits of the robotic technique in subtotal and bilateral adrenalectomy have been discussed in a review article by Nomine-Criqui with equivocal conclusions \[[@CR33]\].

Hospital stay is one of the largest costs in health care. Reports regarding costs associated with different surgical techniques are scarce and most have small patient groups \[[@CR34], [@CR35]\]. Given the higher cost for robotic surgery compared with standard laparoscopy \[[@CR31], [@CR36]\], it remains to be proven if the higher number of patients with large tumours that are operated with robotic surgery instead of an open approach could outweigh the increased costs for this new technique.

In the present study, patients with left-sided tumours had a longer hospital stay compared with patients operated for a tumour on the right side. However, the results are not unequivocal. One study found a longer operative time for right-sided tumours subjected to retroperitoneal endoscopic surgery \[[@CR37]\]. Other investigations found no differences in outcome but longer operation time \[[@CR38]\] and increased risk for surgical complications \[[@CR10]\] in patients with left-sided tumours.

There are some limitations to the present study. The study was based on results from a database with predefined data fields, but data was analysed retrospectively. Although the register is designed for the procedure, i.e. adrenalectomy, important variables such as comorbidity, previous abdominal surgery, blood loss and operative time are missing. For non-surgical complications, for instance pneumonia, venous thrombosis and urinary tract infection, a free text field with ICD coding is available in the database. However, it cannot be ruled out that some of these complications were not coded. Finally, the database does not identify outcomes for the individual surgeon, which may affect the results.

The strength of the present study is that it involved one of the largest national series of patients operated with adrenalectomy. All hospitals that perform adrenal surgery in Sweden participate in the registry and valid data are controlled regularly by an extern audit.

Conclusion {#Sec10}
==========

Within the context of these limitations, the present study shows a low risk for complications, a low conversion rate from endoscopic to open surgery and a short hospital stay for patients undergoing adrenalectomy in Sweden. The study reinforces the benefits of minimal invasive surgery for adrenal tumours on a national level.
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